Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Dentsply Sirona

Forecasting The Future: 7 Analyst Projections For Dentsply Sirona

In the latest quarter, 7 analysts provided ratings for Dentsply Sirona (NASDAQ:XRAY), showcasing a mix of bullish and bearish perspectives.

Stocks Retreat as Hawkish Fed Comments Push Bond Yields Higher

Stocks Retreat as Hawkish Fed Comments Push Bond Yields Higher

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.37%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.32%, and the Nasdaq 100 Index ($IU XX) (QQQ ) closed down -0.67%. Stock indexes on Friday gave up early gains and...

Perth team all smiles at new dental hub opening

Perth team all smiles at new dental hub opening

A city centre dental centre serving customers from across Scotland has opened in Perth

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

What 8 Analyst Ratings Have To Say About Dentsply Sirona

Dentsply Sirona (NASDAQ:XRAY) has observed the following analyst ratings within the last quarter:

Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2022

Why Did Moderna CFO Exit Just A Day After Taking Charge

Moderna Inc (NASDAQ:MRNA) announced that its recently appointed Chief Financial Officer, Jorge Gomez, has departed the company, effective immediately. The announcement follows the public disclosure by Gomez's former employer, Dentsply Sirona Inc (NASDAQ:XRAY), of an ongoing internal investigation into some issues, including financial reporting. The audit investigates Dentsply Sirona's "use of incentives to sell products to…

What 10 Analyst Ratings Have To Say About Dentsply Sirona

Analysts have provided the following ratings for Dentsply Sirona (NASDAQ:XRAY) within the last quarter:

inkl

Read news from The Economist, FT, and more,
with one subscription

Dentsply Sirona's Q1 Earnings Miss Street Expectations, Cuts FY22 Guidance

Dentsply Sirona's Q1 Earnings Miss Street Expectations, Cuts FY22 Guidance

Dentsply Sirona Inc's (NASDAQ:XRAY) Q1 FY22 sales decreased 6.1% Y/Y to $965 million, missing the consensus of $988.43 billion. Adjusted EPS decreased to $0.52 from $0.72 a year ago and missed the consensus of $0.56. "The first quarter was a challenging quarter, and our financial performance and revised outlook reflect the impact…

Recap: Dentsply Sirona Q1 Earnings

Recap: Dentsply Sirona Q1 Earnings

Dentsply Sirona (NASDAQ:XRAY) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Dentsply Sirona Q1 2022 Earnings Conference Call On May 10, 2022 At 08:30 AM ET

Dentsply Sirona Q1 2022 Earnings Conference Call On May 10, 2022 At 08:30 AM ET

Dentsply Sirona (NASDAQ:XRAY) will host a conference call at 08:30 AM ET on May 10, 2022, to discuss Q1 2022 earnings results.

Dentsply Sirona Earnings Conference Call Is Coming Up, Here's What You Need To Know

Dentsply Sirona Earnings Conference Call Is Coming Up, Here's What You Need To Know

Dentsply Sirona (NASDAQ:XRAY) will host a conference call at 08:30 AM ET on May 5, 2022, to discuss Q1 2022 earnings results. How to Attend Dentsply Sirona (XRAY) Conference Call Follow this link to access the live webcast.

Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2022

Expert Ratings for Dentsply Sirona

Expert Ratings for Dentsply Sirona

Over the past 3 months, 7 analysts have published their opinion on Dentsply Sirona (NASDAQ:XRAY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Why Are Dentsply Sirona Shares Plummeting Today?

Why Are Dentsply Sirona Shares Plummeting Today?

Dentsply Sirona Inc (NASDAQ:XRAY) appointed John Groetelaars, who serves on Dentsply Sirona's Board of Directors, as Interim Chief Executive Officer. He succeeds Don Casey, who has been terminated as CEO, and will cease to serve as a member of the Company's Board, effective immediately. The Board has initiated a search to identify…

Get all your
news in one place.

100’s of premium titles.
One news app.

What 4 Analyst Ratings Have To Say About Dentsply Sirona

Within the last quarter, Dentsply Sirona (NASDAQ:XRAY) has observed the following analyst ratings:

Dentsply Sirona's Return On Capital Employed Overview

According to Benzinga Pro data Dentsply Sirona (NASDAQ:XRAY) posted a 0.97% decrease in earnings from Q3. Sales, however, increased by 1.78% over the previous quarter to $1.09 billion.

Dentsply Sirona's Q4 Falls Short Of Expectations, FY22 Sales Outlook Lags Street View

Dentsply Sirona Inc's (NASDAQ: XRAY)

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

290,415 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play